Physician

Ram Lalchandani, M.D.

According to 2025 Medicare claims, Ram Lalchandani, M.D. (NPI: 1114993813) practices hematology/oncology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is SIERRA HEMATOLOGY AND ONCOLOGY MEDICAL CENTERS (NPI: 1992796759; TIN: 680305843) and primary practice location at 95608-0302. Lalchandani is affiliated with the Vivant Health ACO (ACO ID: A5068), participating under the MSSP model.

Lalchandani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 813 traditional Medicare patients, billed 267,956 HCPCS/CPT codes, and received $2,886,463 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,868 prescription claims across 252 beneficiaries totaling $7,208,040 in drug costs, led by Revlimid (Lenalidomide). DME data shows 25 claims. Open Payments data shows 30 records totaling $2,408. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,168,962 to $2,886,463. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,442,482 to $7,208,040. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,109 to $377.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $1,168,962 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,328,868 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,330,104 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,634,182 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,572,715 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,455,656 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,751,245 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,218,681 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,883,853 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,886,463 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201543698,701$1,168,962
2016409115,868$1,328,868
2017380122,549$1,330,104
2018423109,970$1,634,182
201955998,994$1,572,715
2020556111,443$1,455,656
2021543144,173$1,751,245
2022703206,776$2,218,681
2023805196,662$1,883,853
2024813267,956$2,886,463

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.8M$7.6M2015 Drug cost: $1,442,482 (USD; Tot_Drug_Cst)2016 Drug cost: $1,923,205 (USD; Tot_Drug_Cst)2017 Drug cost: $2,516,887 (USD; Tot_Drug_Cst)2018 Drug cost: $3,219,464 (USD; Tot_Drug_Cst)2019 Drug cost: $3,859,772 (USD; Tot_Drug_Cst)2020 Drug cost: $6,259,359 (USD; Tot_Drug_Cst)2021 Drug cost: $5,331,380 (USD; Tot_Drug_Cst)2022 Drug cost: $7,421,555 (USD; Tot_Drug_Cst)2023 Drug cost: $7,593,094 (USD; Tot_Drug_Cst)2024 Drug cost: $7,208,040 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151671,172$1,442,482
20161571,167$1,923,205
20171741,198$2,516,887
20181881,331$3,219,464
20192171,485$3,859,772
20202521,716$6,259,359
20212771,860$5,331,380
20223352,051$7,421,555
20232751,940$7,593,094
20242521,868$7,208,040

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.8K$14K2015 Medicare payment: $13,656 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,945 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,427 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $6,116 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,810 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,758 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,342 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,308 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $263 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $408 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201511157$13,656
2016N/R63$5,945
2017N/R22$1,427
2018N/R35$6,116
2019N/R26$1,810
2020N/R25$1,758
2021N/R82$4,342
2022N/R34$1,308
2023N/R14$263
2024N/R25$408

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3531,073$102
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more420615$66
80053Blood test, comprehensive group of blood chemicals105420$10
36415Insertion of needle into vein for collection of blood sample3451,140$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3531,660$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide751,967$1,325,667
IbrancePalbociclib30840$457,471
LenalidomideLenalidomide38896$413,599
CalquenceAcalabrutinib Maleate31930$388,220
TibsovoIvosidenib12360$388,146

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$245
K0001Standard wheelchairYN/R12$163

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$2,408US Oncology Corporate, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ram Lalchandani, M.D.?

Tedicare shows public-source Medicare data for Ram Lalchandani, M.D. (NPI 1114993813), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ram Lalchandani, M.D. have ACO affiliation data?

Ram Lalchandani, M.D. is shown with ACO affiliation data for Vivant Health ACO (MSSP, ACO ID A5068).

What billing organization is linked to Ram Lalchandani, M.D.?

Ram Lalchandani, M.D. is linked to SIERRA HEMATOLOGY AND ONCOLOGY MEDICAL CENTERS (billing NPI 1992796759) in the available physician profile data.

Does Ram Lalchandani, M.D. have Open Payments data?

Ram Lalchandani, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.